Literature DB >> 7848519

The Th1-Th2 hypothesis of HIV infection: new insights.

M Clerici1, G M Shearer.   

Abstract

In their earlier, much quoted, viewpoint article, Mario Clerici and Gene Shearer examined the role of T helper 1 (Th1)- and Th2-type responses in immune dysregulation associated with human immunodeficiency virus (HIV) infection. In this article, they consider the complications of a Th1-Th2 model raised by the nomenclature, discuss the issue of cytokine production by non-T cells, and compare data obtained from T-cell clones with heterogeneous populations of leukocytes from patients. They define Th-cell responses and cytokine profiles as 'type 1' and 'type 2', and reemphasize the importance of strong cellular immune responses, along with the cytokines that augment and maintain such responses, in protective immunity against HIV infection and AIDS progression. Finally, they present a model of activation-induced, cytokine-modulated, programmed cell death as a major factor in the pathogenesis of HIV infection and AIDS.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7848519     DOI: 10.1016/0167-5699(94)90220-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  126 in total

Review 1.  The immune system in the elderly: III. Innate immunity.

Authors:  L Ginaldi; M De Martinis; A D'Ostilio; L Marini; M F Loreto; D Quaglino
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 2.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

3.  Regeneration and tolerance factor: a correlate of human immunodeficiency virus-associated T-cell activation.

Authors:  T S Givens; B K DuChateau; J S Boomer; M P Westerman; A Gilman-Sachs; K D Beaman
Journal:  Clin Diagn Lab Immunol       Date:  1999-11

Review 4.  Human gamma delta T lymphocytes in HIV disease: effector functions and control by natural killer cell receptors.

Authors:  M L Gougeon; F Poccia; S Boullier
Journal:  Springer Semin Immunopathol       Date:  2000

Review 5.  Host background immunity and human immunodeficiency virus protective vaccines, a major consideration for vaccine efficacy in Africa and in developing countries.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Diagn Lab Immunol       Date:  2002-05

Review 6.  Immunological effects of interleukin-2 therapy in human immunodeficiency virus-positive subjects.

Authors:  P De Paoli
Journal:  Clin Diagn Lab Immunol       Date:  2001-07

7.  T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity.

Authors:  A Giovannetti; M Pierdominici; F Mazzetta; S Salemi; M Marziali; D Kuonen; F Iebba; E A Lusi; A Cossarizza; F Aiuti
Journal:  Clin Exp Immunol       Date:  2001-04       Impact factor: 4.330

8.  Immunological markers of disease progression in patients infected with the human immunodeficiency virus.

Authors:  J M Pascale; M D Isaacs; P Contreras; B Gomez; L Lozano; E Austin; M C De Martin; R L Gregory; G L McLaughlin; A Amador
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

9.  Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection.

Authors:  W P Cheevers; J C Beyer; D P Knowles
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 10.  Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy.

Authors:  Gadi Borkow; Zvi Bentwich
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.